196 related articles for article (PubMed ID: 9212741)
21. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
22. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
Gillett CE; Smith P; Peters G; Lu X; Barnes DM
J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095
[TBL] [Abstract][Full Text] [Related]
23. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
Cheng JD; Werness BA; Babb JS; Meropol NJ
Clin Cancer Res; 1999 May; 5(5):1057-62. PubMed ID: 10353738
[TBL] [Abstract][Full Text] [Related]
24. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
[TBL] [Abstract][Full Text] [Related]
25. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
26. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells.
Wu M; Bellas RE; Shen J; Yang W; Sonenshein GE
J Immunol; 1999 Dec; 163(12):6530-5. PubMed ID: 10586045
[TBL] [Abstract][Full Text] [Related]
27. [Role of p27Kip1 protein in the cell cycle and its appearance in lymphoid tissues, particularly non-Hodgkin's B-cell lymphomas. Review].
Boudová L; Vanĕcek T; Síma R; Bouda J; Hes O; Fakan F
Cesk Patol; 2003 Jul; 39(3):126-9. PubMed ID: 14631810
[TBL] [Abstract][Full Text] [Related]
28. Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival.
Flørenes VA; Maelandsmo GM; Kerbel RS; Slingerland JM; Nesland JM; Holm R
Am J Pathol; 1998 Jul; 153(1):305-12. PubMed ID: 9665492
[TBL] [Abstract][Full Text] [Related]
29. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
30. P53 protein expression in lymphomas and reactive lymphoid tissue.
Villuendas R; Piris MA; Orradre JL; Mollejo M; Algara P; Sanchez L; Martinez JC; Martinez P
J Pathol; 1992 Mar; 166(3):235-41. PubMed ID: 1381424
[TBL] [Abstract][Full Text] [Related]
31. Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas.
Oh YH; Park CK
J Korean Med Sci; 2000 Aug; 15(4):399-406. PubMed ID: 10983687
[TBL] [Abstract][Full Text] [Related]
32. Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1.
Gloghini A; Gaidano G; Larocca LM; Pierconti F; Cingolani A; Dal Maso L; Capello D; Franceschi S; Tirelli U; Libra M; Niu H; Dalla-Favera R; Carbone A
Am J Pathol; 2002 Jul; 161(1):163-71. PubMed ID: 12107101
[TBL] [Abstract][Full Text] [Related]
33. Proliferation in HHV-8-positive primary effusion lymphomas is associated with expression of HHV-8 cyclin but independent of p27(kip1).
Carbone A; Gloghini A; Bontempo D; Monini P; Tirelli U; Volpe R; Browning PJ; Gaidano G
Am J Pathol; 2000 Apr; 156(4):1209-15. PubMed ID: 10751346
[TBL] [Abstract][Full Text] [Related]
34. Protein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma.
Kudoh S; Kumaravel TS; Kuramavel B; Eguchi M; Asaoku H; Dohy H; Fujiwara M; Sasaki N; Tanaka K; Kamada N
Jpn J Cancer Res; 1999 Nov; 90(11):1262-9. PubMed ID: 10622539
[TBL] [Abstract][Full Text] [Related]
35. Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.
Sánchez-Beato M; Sáez AI; Navas IC; Algara P; Sol Mateo M; Villuendas R; Camacho F; Sánchez-Aguilera A; Sánchez E; Piris MA
Am J Pathol; 2001 Jul; 159(1):205-13. PubMed ID: 11438467
[TBL] [Abstract][Full Text] [Related]
36. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
37. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue.
Wołowiec D; Benchaib M; Pernas P; Deviller P; Souchier C; Rimokh R; Felman P; Bryon PA; Ffrench M
Leukemia; 1995 Aug; 9(8):1382-8. PubMed ID: 7643628
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of cyclin-dependent kinase inhibitor p27Kip1 expression and proliferation in non-Hodgkin's lymphoma: independent prognostic value of p27Kip1.
Moller MB; Skjodt K; Mortensen LS; Pedersen NT
Br J Haematol; 1999 Jun; 105(3):730-6. PubMed ID: 10354138
[TBL] [Abstract][Full Text] [Related]
39. Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction.
Martínez JC; Piris MA; Sánchez-Beato M; Villuendas R; Orradre JL; Algara P; Sánchez-Verde L; Martínez P
J Pathol; 1993 Apr; 169(4):405-12. PubMed ID: 8501537
[TBL] [Abstract][Full Text] [Related]
40. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.
Chiarle R; Budel LM; Skolnik J; Frizzera G; Chilosi M; Corato A; Pizzolo G; Magidson J; Montagnoli A; Pagano M; Maes B; De Wolf-Peeters C; Inghirami G
Blood; 2000 Jan; 95(2):619-26. PubMed ID: 10627471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
